New hope for chronic eye GVHD: expanded access to d-MAPPS eye drops
NCT ID NCT07210619
First seen Oct 31, 2025 · Last updated May 08, 2026 · Updated 33 times
Summary
This program provides early access to an investigational eye drop called d-MAPPS for people suffering from chronic ocular Graft-Versus-Host Disease (oGVHD), a painful eye condition that can occur after a stem cell or bone marrow transplant. It is for adults aged 18 and older who have moderate to severe dry eye symptoms and meet specific health criteria. The goal is to offer treatment outside of a clinical trial while the drug is still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OGVHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.